Reyon Pharmaceutical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Reyon Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer (NCT01895491) | Reyon Pharmaceutical Co., Ltd. | 2011-03-01 |
Track Reyon Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.